Checkmate Pharmaceuticals Inc. Soared

Tue, Apr 19, 2022 at 05:30 PM
Checkmate Pharmaceuticals Inc. Soared

Checkmate Pharmaceuticals Inc. (CMPI:NASDAQ) shot up at $10.35, a gain of 325.9%. On Mon, Apr 18, 2022, CMPI:NASDAQ touched a New 2-Week Low of $2.41. The stock appeared on our News Catalysts scanner on Tue, Apr 19, 2022 at 03:08 PM in the 'ACQUISITION' category. From Tue, Apr 05, 2022, the stock recorded 12.50% Up Days and 22.22% Green Days

About Checkmate Pharmaceuticals Inc. (CMPI:NASDAQ)

Checkmate Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing its proprietary technology to harness the power of the immune system to combat cancer.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.